Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies von Phillip, Moshe, Mathieu, Chantal, Lind, Marcus, Araki, Eiichi, Bartolo, Paolo, Bergenstal, Richard, Heller, Simon, Hansen, Lars, Scheerer, Markus Florian, Thoren, Fredrik, Arya, Niki, Xu, John, Iqbal, Nayyar, Dandona, Paresh

Volltext

Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure von Vaduganathan, Muthiah, Claggett, Brian L, Kulac, Ian J, Miao, Zi Michael, Desai, Akshay S, Jhund, Pardeep S, Henderson, Alasdair D, Brinker, Meike, Lay-Flurrie, James, Viswanathan, Prabhakar, Scheerer, Markus Florian, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv J, Voors, Adriaan A, Zannad, Faiez, Pitt, Bertram, McMurray, John J.V., Solomon, Scott D

Volltext

Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure von Vaduganathan, Muthiah, Claggett, Brian L, Kulac, Ian J, Miao, Zi Michael, Desai, Akshay S, Jhund, Pardeep S, Henderson, Alasdair D, Brinker, Meike, Lay-Flurrie, James, Viswanathan, Prabhakar, Scheerer, Markus Florian, Lage, Andrea, Lam, Carolyn S P, Senni, Michele, Shah, Sanjiv J, Voors, Adriaan A, Zannad, Faiez, Pitt, Bertram, McMurray, John J V, Solomon, Scott D

Volltext

Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2 von Mathieu, Chantal, Dandona, Paresh, Birkenfeld, Andreas L, Hansen, Troels Krarup, Iqbal, Nayyar, Xu, John, Repetto, Enrico, Scheerer, Markus Florian, Thoren, Fredrik, Phillip, Moshe

Volltext

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT‐1 and ‐2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2 von Mathieu, Chantal, Dandona, Paresh, Birkenfeld, Andreas L, Hansen, Troels Krarup, Iqbal, Nayyar, Xu, John, Repetto, Enrico, Scheerer, Markus Florian, Thoren, Fredrik, Phillip, Moshe

Volltext

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT‐1 and ‐2 trials in individuals with type 1 diabetes and body mass index ≥27kg/m2 von Mathieu, Chantal, Dandona, Paresh, Birkenfeld, Andreas L, Troels Krarup Hansen, Nayyar Iqbal, Xu, John, Repetto, Enrico, Markus Florian Scheerer, Thoren, Fredrik, Moshe, Phillip

Volltext

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m 2 von Mathieu, Chantal, Dandona, Paresh, Birkenfeld, Andreas L, Hansen, Troels Krarup, Iqbal, Nayyar, Xu, John, Repetto, Enrico, Scheerer, Markus Florian, Thoren, Fredrik, Phillip, Moshe

Volltext

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and-2 studies von Phillip, Moshe, Mathieu, Chantal, Lind, Marcus, Araki, Eiichi, di Bartolo, Paolo, Bergenstal, Richard, Heller, Simon, Hansen, Lars, Scheerer, Markus Florian, Thoren, Fredrik, Arya, Niki, Xu, John, Iqbal, Nayyar, Dandona, Paresh

Volltext

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme von Gordon, Jason, Danne, Thomas, Beresford-Hulme, Lee, Bennet, Hayley, Tank, Amarjeet, Edmonds, Christopher, Thorén, Fredrik, Scheerer, Markus Florian, McEwan, Phil

Volltext

TREATMENT OF CHRONIC KIDNEY DISEASE IN TYPE I DIABETES MELLITUS von SCHEERER, Markus Florian, LAWATSCHECK, Robert, KOLKHOF, Peter, EDFORS, Robert, BRINKER, Meike Daniela

Volltext bestellen

Treatment of chronic kidney disease in type I diabetes mellitus von SCHEERER, MARKUS FLORIAN, LAWATSCHECK, ROBERT, BRINKER, MEIKE DANIELA, EDFORS, ROBERT, KOLKHOF, PETER

Volltext bestellen

Adverse Changes in HbA1c, Body Weight and Insulin Use in People With Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme von Gordon, Jason, Danne, Thomas, Beresford-Hulme, Lee, Bennet, Hayley, Tank, Amarjeet, Edmonds, Christopher, Thorén, Fredrik, Scheerer, Markus Florian, McEwan, Phil

Volltext bestellen

Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany von Erber, Johanna, Kappler, Verena, Haller, Bernhard, Mijočević, Hrvoje, Galhoz, Ana, Prazeres da Costa, Clarissa, Gebhardt, Friedemann, Graf, Natalia, Hoffmann, Dieter, Thaler, Markus, Lorenz, Elke, Roggendorf, Hedwig, Kohlmayer, Florian, Henkel, Andreas, Menden, Michael P, Ruland, Jürgen, Spinner, Christoph D, Protzer, Ulrike, Knolle, Percy, Lingor, Paul

Volltext

Die Substitution von Dienstleistungen durch Informationsprodukte auf elektronischen Märkten von Bieberbach, Florian, Hermann, Michael

Volltext